- Home
- NMRA vs GDEV Comparison
NMRA vs GDEV Comparison
Compare NMRA & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- GDEV
- Stock Information
- Founded
- NMRA 2019
- GDEV 2009
- Country
- NMRA United States
- GDEV Cyprus
- Employees
- NMRA N/A
- GDEV N/A
- Industry
- NMRA
- GDEV EDP Services
- Sector
- NMRA
- GDEV Technology
- Exchange
- NMRA Nasdaq
- GDEV Nasdaq
- Market Cap
- NMRA 287.6M
- GDEV 282.9M
- IPO Year
- NMRA 2023
- GDEV N/A
- Fundamental
- Price
- NMRA $1.80
- GDEV $20.90
- Analyst Decision
- NMRA Strong Buy
- GDEV Buy
- Analyst Count
- NMRA 6
- GDEV 2
- Target Price
- NMRA $20.67
- GDEV $70.00
- AVG Volume (30 Days)
- NMRA 2.0M
- GDEV 20.7K
- Earning Date
- NMRA 03-06-2025
- GDEV 03-18-2025
- Dividend Yield
- NMRA N/A
- GDEV N/A
- EPS Growth
- NMRA N/A
- GDEV N/A
- EPS
- NMRA N/A
- GDEV 2.04
- Revenue
- NMRA N/A
- GDEV $432,534,000.00
- Revenue This Year
- NMRA N/A
- GDEV N/A
- Revenue Next Year
- NMRA N/A
- GDEV $9.01
- P/E Ratio
- NMRA N/A
- GDEV $10.24
- Revenue Growth
- NMRA N/A
- GDEV N/A
- 52 Week Low
- NMRA $1.60
- GDEV $14.26
- 52 Week High
- NMRA $21.00
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- NMRA 27.76
- GDEV 67.29
- Support Level
- NMRA $1.61
- GDEV $14.26
- Resistance Level
- NMRA $1.80
- GDEV $15.80
- Average True Range (ATR)
- NMRA 0.11
- GDEV 1.17
- MACD
- NMRA 0.23
- GDEV 0.50
- Stochastic Oscillator
- NMRA 51.28
- GDEV 63.03
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.